Related Experiment Video
Updated: Jan 7, 2026

12:18
A Murine Model of a Burn Wound Reconstructed with an Allogeneic Skin Graft
Published on: August 8, 2020
10.8K
Neo-Dermis Formation and Graft Timing After ADM Reconstruction: A Cohort Study with Histological Validation
Daniel Pit1,2,3,4, Teodora Hoinoiu2,3,4, Bogdan Hoinoiu5,6
1Doctoral School, "Victor Babes" University of Medicine and Pharmacy, E. Murgu Square, No. 2, 300041 Timisoara, Romania.
Journal of Functional Biomaterials
|December 24, 2025
Summary
Acellular dermal matrices (ADMs) allow for split-thickness skin grafting (STSG) around day 14 post-reconstruction. This early grafting strategy is safe and effective across different ADM types, showing similar patient outcomes and low complication rates.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Plastic and Reconstructive Surgery
Background:
- Acellular dermal matrices (ADMs) are crucial for soft-tissue reconstruction.
- Optimal timing for split-thickness skin grafting (STSG) onto ADMs is not well-established.
- Existing ADMs include Integra® Double Layer (IDL), Integra® Single Layer (ISL), and Nevelia®.
Purpose of the Study:
- To evaluate the impact of ADM type on reconstruction outcomes.
- To determine the optimal timing for STSG in ADM-based reconstructions.
- To assess in-hospital complications and spontaneous epithelialization rates.
Main Methods:
- Retrospective cohort study of 75 adult patients undergoing ADM reconstruction.
- Analysis of length of stay, STSG timing, and complications.
- Histological and immunohistochemical analysis (H&E, Masson trichrome, CD105, D2-40) for matrix integration and vascularization.
Main Results:
- No significant difference in length of stay or complications based on ADM type.
- A day-14 STSG strategy was feasible in 40% of patients without increased complications.
- Histology confirmed neo-dermis maturation by 3-6 weeks, supporting early grafting.
- Spontaneous epithelialization occurred in 4% of patients.
Conclusions:
- ADM type did not independently predict length of stay or complications.
- A criteria-based, early STSG approach (~day 14) is safe and operationally advantageous.
- Further multicenter studies are needed to refine patient selection and graft timing.

